Boule Diagnostics AB (publ) (STO: BOUL)
Sweden
· Delayed Price · Currency is SEK 6.78
+0.04 (0.59%)
Nov 19, 2024, 4:29 PM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 264.84 million as of November 21, 2024. Its market cap has decreased by -27.83% in one year.
Market Cap
264.84M
Enterprise Value
425.94M
Revenue
563.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.78
Market Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has increased from 162.45M to 264.84M, an increase of 63.03%. That is a compound annual growth rate of 3.71%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,129.73B |
| Swedish Orphan Biovitrum AB (publ) | 103.10B |
| Sectra AB (publ) | 52.52B |
| Getinge AB (publ) | 46.60B |
| Camurus AB (publ) | 32.11B |
| Vitrolife AB (publ) | 28.97B |
| Medicover AB (publ) | 26.15B |
| Elekta AB (publ) | 24.07B |